Evidence map›Paper›PMID 35576352›Full record

ArticleObstetrics and gynecology2022

Postpartum Follow-up Care for Pregnant Persons With Opioid Use Disorder and Hepatitis C Virus Infection.

Marian Jarlenski, Qingwen Chen, Katherine A Ahrens, Lindsay Allen, Anna E Austin, Catherine Chappell, Julie M Donohue, Lindsay Hammerslag, Paul Lanier, Mary Joan McDuffie and 4 more

Registry-linked trialOpen access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Obstetrics and gynecology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06367465 (Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06367465 recruitingnot on this mapstarted 2024, after this paper: background citation

Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy

TypeobservationalSponsorWashington University School of MedicineRan2024 to 2026Enrolled50ConditionsHepatitis C, Pregnancy ComplicationsArmsGlecaprevir-pibrentasvir
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  3. Article
  4. Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Hepatitis C virus in childhood and pregnancy.Infectious diseases & immunity · 2025
    Review
  9. Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Marian JarlenskiDepartment of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania; the Muskie School of Public Service, University of Southern Maine, Portland, Maine; the Department of Health Policy, Management, and Leadership, West Virginia University School of Public Health, Morgantown, West Virginia; the Department of Maternal and Child Health, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina; the Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; the Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky; the School of Social Work, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; the Center for Community Research and Service, University of Delaware, Newark, Delaware; and the Department of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
Qingwen Chen
Katherine A Ahrens
Lindsay Allen
Anna E Austin
Catherine Chappell
Julie M Donohue
Lindsay Hammerslag
Paul Lanier
Mary Joan McDuffie
Jeffrey Talbert
Lu Tang
Elizabeth E Krans
Medicaid Outcomes Distributed Research Network (MODRN)
Magee-Womens Research Institute · US

Funding

Examining the quality of opioid use disorder treatment in a Medicaid research networkR01DA048029 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONOHUE, JULIE MARIE · 2019 to 2021
$3.5M
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomesR01DA045675 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JARLENSKI, MARIAN PATRICIA, KRANS, ELIZABETH E · 2018 to 2022
$3.4M
NIDA NIH HHS R01 DA045675NIDA NIH HHS R01 DA048029
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis COpioid-Related DisordersPregnancy Complications, InfectiousAftercareFemaleHepacivirusHumansPostpartum PeriodPregnancy

Identifiers

PMID35576352
PMCPMC9170182
OpenAlexW4280564469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.